← Leaderboards
Andrew R Moss
University Of California San Francisco
$5,991,321
Attributed
$5,991,321
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$5,991,321 · 2
By mechanism
R01$5,991,321 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Elise D Riley$16,115,559
- Kenneth E. Covinsky$13,413,116
- David Roy Bangsberg$24,881,545
- Diane W. Wara$7,985,315
- Ann Petru$791,951
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsHuman Therapy EvaluationHuman SubjectEpidemiologyLongitudinal Human StudyClinical ResearchHepatitis CDisease /Disorder Proneness /RiskDrug ResistanceHepatitis BHepatitis VaccineHomelessAdolescence (12-20)Aids TherapyAspartic EndopeptidasesClinical TrialsCombination ChemotherapyCommunity Health ServicesComorbidityVirus GeneticsVirus LoadYoung Adult Human (21-34)ImmunizationInterview
Grant awards (6)
HIV Treatment in the homeless: a prospective study$1,626,607
R01 · FY2002 · MH
PROTEASE INHIBITORS IN THE HOMELESS--A COHORT STUDY$1,304,088
R01 · FY2001 · MH
HIV AND HEPATITIS IN YOUNG INJECTORS: A COMMUNITY STUDY$782,773
R01 · FY2001 · DA
HIV AND HEPATITIS IN YOUNG INJECTORS: A COMMUNITY STUDY$124,668
R01 · FY2001 · DA
PROTEASE INHIBITORS IN THE HOMELESS--A COHORT STUDY$1,343,847
R01 · FY2000 · MH
HIV AND HEPATITIS IN YOUNG INJECTORS: A COMMUNITY STUDY$809,338
R01 · FY2000 · DA